The latest price target for SI-BONE (NASDAQ:SIBN) was reported by Truist Securities on April 15, 2026. The analyst firm set a price target for $20.00 expecting SIBN to rise to within 12 months (a possible 40.35% upside). 13 analyst firms have reported ratings in the last year.

The latest analyst rating for SI-BONE (NASDAQ:SIBN) was provided by Truist Securities, and SI-BONE maintained their buy rating.

There is no last upgrade for SI-BONE

There is no last downgrade for SI-BONE.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SI-BONE, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SI-BONE was filed on April 15, 2026 so you should expect the next rating to be made available sometime around April 15, 2027.

While ratings are subjective and will change, the latest SI-BONE (SIBN) rating was a maintained with a price target of $24.00 to $20.00. The current price SI-BONE (SIBN) is trading at is $14.25, which is out of the analyst’s predicted range.